Table 2

 Mean body burden of PCDD/Fs and selected PCBs in zones A (near industry) and C (away from industry) in ng/kg lipid base

Full sample, mean (SD)Zone AZone CDifference in means: A − C (95% CI)
*DF = PCDD/Fs.
†D = PCDD.
‡F = PCDF.
WHO-TEQ (DF+PCB)*47.0 (15.3)45.348.6−3.3 (−13.2 to 6.7)
WHO-TEQ (D)†21.1 (6.8)20.721.6−1.0 (−5.3 to 3.4)
WHO-TEQ (F)‡8.7 (3.1)8.49.1−0.7 (−2.7 to 1.3)
WHO-TEQ (DF)29.9 (9.7)29.130.8−1.7 (−8.0 to 4.6)
WHO-TEQ (PCB)17.1 (6.5)16.317.9−1.7 (−5.9 to 2.6)
I-TEQ26.0 (8.4)25.426.5−1.2 (−6.6 to 4.2)
PCB 11816200 (9900)1400018400−440 (−10900 to 1300
PCB 15613100 (4280)1320013000−200 (−2600 to 3000)
PCB 118:1561.3 (0.7)1.21.4−0.2 (−0.7 to 0.3)
Sample size402020